668 N. Riverpoint Blvd
Washington State University
Spokane, WA 99210
Professor, Health Policy & Administration
Ph.D., University of California, Berkeley
Master of Art, Claremont Graduate School
Bachelor of Art, Whitman College
HPA 500: Introduction to the Health Care System
HPA 501: Health Care Policy and Politics
HPA 580: Disability and Aging Policy
HPA 590: Strategic Management and Marketing
INTERESTS & EXPERTISE
- Disability and aging services
- Rehabilitation, and long term care policy
- Program evaluation
WA Attorney General’s Office, Consumer Protective Division, $340,288. The Antipsychotic Atlas: Medicare Usage of Antipsychotic Medications in Washington. J Kennedy, PI. [September 2013-August 2015)
WA Life Sciences Discovery Fund, $4,048,620. Program of Excellence in Rural Mental Health and Substance Abuse Treatment. J Kennedy, Head of Policy Core (5%); J Roll, PI. [April 2009 - March 2014]
2007-Present: Editorial Board Member The Open Health Services & Policy Journal
1996-Present: Editorial Board Member Journal of Disability Policy Studies
2010: Graduate Advisor Award, Graduate and Professional Students Association, Washington State University
2009: Faculty Excellence Award, Washington State University
2009: Award for Excellence (Nominee). Journal of Managed Care Pharmacy
2006–2008: Certificate of Excellence in Teaching, Associated Students of Washington State University Spokane
1999–2000: Distinguished Research Fellow, National Institute of Disability and Rehabilitation Research, U.S. Department of Education
1998: Zimmer New Investigator Award (Honorable Mention), Gerontological Health Section of the American Public Health Association
1998: Arnold O. Beckman Research Award, University of Illinois
1992: Emerging Scholar Award, Society for Disability Studies
Kennedy, J, E Blodgett & G Gimm (2013). Return to work: A critical aspect of care coordination for younger dual eligibles. Disability and Health (in press).
Roll, J, J Kennedy, M Tran & D Howell (2013). Disparities in unmet need for mental health services in the US, 1997-2010. Psychiatric Services, 64(1).
Kennedy, J & E Blodgett (2012). Health Insurance–Motivated Disability Enrollment and the ACA. New England Journal of Medicine, 367, e16.
Boe, R, J Kennedy, J Coyne & G Smith (2012). Implementation of paperless credentialing in a multi-state managed care organization. American Journal of Managed Care, 18(1), e31-34.
Wu, C, C Wang & J Kennedy (2011). Herbal supplement use in the U.S. adult population: results from 2002 and 2007 National Health Interview Survey. Clinical Therapeutics, 33 (11), 1749-1758.
Kennedy, J, M Maciejewski, D Liu, E Blodgett (2011). Cost related nonadherence in the Medicare program - the impact of Part D. Medical Care, 49(5), 522-526.
Morgan, S, & J Kennedy (2010). Prescription drug accessibility and affordability in the United States and abroad: Commonwealth Fund Issue Brief, NYC: Commonwealth Fund
Kennedy, J, A Dipzinski, J Roll, J Coyne & E Blodgett (in press, 2010). Medicare Prescription Drug Plan Coverage of Pharmacotherapies for Opioid and Alcohol Dependence in WA. Drug and Alcohol Dependence
Kennedy, J, Y Tien, L Cohen, D Sclar, D Liu E Blodgett & J Engle (2009). The association between class of antipsychotic and the rates of hospitalization: results of a retrospective analysis of the 2005 Medicare Beneficiary Survey. Clinical Therapeutics, 31(12),2931-2939.
Wu, M, J Kennedy, L Cohen, & C Wang (2009). Coverage of atypical antipsychotics among Medicare Drug Plans in Washington State: Changes between 2007 and 2008. Prim Care Companion, J Clin Psychiatry, 11(6):316-321
Morgan, S, J Kennedy, K Booth, D Watson & E Roughead (2009). Toward an understanding of high performance pharmaceutical policy systems: a ‘triple-A’ framework and example analysis. Open Health Services and Policy Journal,9(2), 1-9
Kennedy, J & S Morgan (2009). Cost related prescription nonadherence in the U S and Canada: a system level comparison using the 2007 International Health Perspectives Survey. Clinical Therapeutics, 31(1), 213-219Wu, C, S Erikson & J Kennedy (2009). Patient characteristics associated with medication use among people diagnosed with DSM-IV mood disorders: results from the National Comorbidity Survey Replication (NCS-R). Current Medical Research and Opinion, 25(2), 471-482